SVA — Sinovac Biotech Balance Sheet
0.000.00%
Last trade - 00:00
HealthcareMicro Cap
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 177 | 203 | 1,176 | 13,415 | 11,313 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 77.5 | 114 | 253 | 952 | 609 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 284 | 350 | 1,560 | 14,915 | 12,126 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 70.9 | 80.9 | 284 | 1,019 | 1,052 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 370 | 452 | 1,901 | 16,748 | 14,115 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 58.2 | 87.2 | 680 | 2,413 | 1,092 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 116 | 158 | 1,155 | 7,421 | 5,193 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 253 | 294 | 746 | 9,327 | 8,921 |
Total Liabilities & Shareholders' Equity | 370 | 452 | 1,901 | 16,748 | 14,115 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |